Partially Mismatched Stem Cell Transplant

Reduced Intensity, Partially HLA Mismatched Allogeneic BMT for Hematologic Malignancies Using Donors Other Than First-degree Relatives

More Information

Trial Status
Accepting patients
Trial Phase
Phase 1/2
Enrollment
100 patients (estimated)
Sponsors
Sidney Kimmel Cancer Center
Collaborators
National Cancer Institute (NCI)
Tags
Allogeneic Stem Cell Transplant, Chemotherapy, Radiation Therapy
Trial Type
Treatment
Last Update
3 weeks ago
SparkCures ID
1700
NCT Identifier
NCT01203722

Real People. Real Support.

Need help connecting with this clinical trial? We're here to help!

Print a patient-friendly report to share with your patient.

We can help answer any questions and connect you (or your patient) with the study team.

Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.